EUVIMEDEUVIMED entdecken
Crossref

Papain‐Like Protease of SARS‐CoV‐2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors

Fang Wu, Zhaoyong Zhang, Qili Lun, Xu Hong, Jiantao Chen, Xinfeng Xu, Xinyi Xiong, Ying Zhang, Dmitry N Shcherbakov, Shuwen Liu, Yaoqi Zhou, Yanqun Wang und 3 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Fang Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of New Drug Screening & NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong-Hong Kong-…. Hauptthemen laut MEDLINE: Cytokines, Ubiquitins, SARS-CoV-2, Coronavirus Papain-Like Proteases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China (82304569, 82130101, 82173865), Guangdong Basic and Applied Basic Research Foundat….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS‐CoV‐2 papain‐like protease (PLpro) is a multifunctional viral protein that facilitates viral assembly and disrupts host immune responses by removing interferon‐stimulated gene 15 (ISG15) modifications from target proteins. However, the mechanisms by which PLpro‐mediated immune evasion leads to inflammatory responses are not well understood. In this study, we demonstrate for the first time that PLpro induces inflammation in colonic epithelial cells and colonic inflammation in a mouse model, acting through the ISG15 signaling pathway. Using high‐throughput screening, we identified two natural product‐derived compounds, coptisine sulfate and (+)‐shikonin, that inhibit the interaction between PLpro and ISG15 at the PLpro/ISG15 interface. We further investigated the mechanism of action of these two inhibitors using surface plasmon resonance, thermal shift assays, molecular docking, and molecular simulation studies. Importantly, both coptisine sulfate and (+)‐shikonin were able to reduce intestinal inflammation in the PLpro‐induced mouse model. These findings provide novel insights into how the SARS‐CoV‐2 PLpro can drive inflammatory responses and introduce two natural compound‐based inhibitors that may offer a new approach to alleviate gastrointestinal complications associated with COVID‐19 infection. Our results highlight the potential of targeting the PLpro/ISG15 interaction as a therapeutic strategy against SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesUbiquitinsSARS-CoV-2Coronavirus Papain-Like ProteasesAnimalsMiceHumansBerberineMolecular Docking SimulationCOVID-19Signal TransductionDisease Models, AnimalInflammationMice, Inbred C57BL

Stichwörter der Autor:innen

(+)‐ShikoninCOVID‐19PLpro inhibitorPLpro‐induced intestinal inflammationcoptisine sulfate

Substanzen

CytokinesUbiquitinsBerberineCoronavirus Papain-Like ProteasesISG15 protein, humanpapain-like protease, SARS-CoV-2G1p2 protein, mouse

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of New Drug Screening & NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutica…
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
  • Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • State Research Center of Virology and Biotechnology VECTOR, Koltsovo, Russia.
  • Department of Physical-Chemistry Biology and Biotechnology, Altai State University, Barnaul, Russia.

ORCID-Profile: Wei Xu

Förderung

  • This study was supported by the National Natural Science Foundation of China (82304569, 82130101, 82173865), Guangdong Basic and Applied Basic Research Foundat…

Zitieren

APA

Wu, F., Zhang, Z., Lun, Q., Hong, X., Chen, J., Xu, X., Xiong, X., Zhang, Y., Shcherbakov, D. N., Liu, S., Zhou, Y., Wang, Y., Zhan, J., Zhao, J., & Xu, W. (2025). Papain‐Like Protease of SARS‐CoV‐2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors. Journal of Medical Virology. https://doi.org/10.1002/jmv.70448

Vancouver

Wu F, Zhang Z, Lun Q, Hong X, Chen J, Xu X, et al. Papain‐Like Protease of SARS‐CoV‐2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors. Journal of Medical Virology. 2025. doi:10.1002/jmv.70448

BibTeX
@article{Wu2025,
  author = {Wu, Fang and Zhang, Zhaoyong and Lun, Qili and Hong, Xu and Chen, Jiantao and Xu, Xinfeng and Xiong, Xinyi and Zhang, Ying and Shcherbakov, Dmitry N and Liu, Shuwen and Zhou, Yaoqi and Wang, Yanqun and Zhan, Jian and Zhao, Jincun and Xu, Wei},
  title = {Papain‐Like Protease of SARS‐CoV‐2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70448}
}
Kostenlos starten →